HCW Biologics Inc.

0.31
0.01 (2.58%)
At close: Mar 27, 2025, 3:59 PM
0.30
-1.70%
After-hours: Mar 27, 2025, 07:46 PM EDT
2.58%
Bid 0.28
Market Cap 13.6M
Revenue (ttm) 4.12M
Net Income (ttm) -43.97M
EPS (ttm) -1.01
PE Ratio (ttm) -0.3
Forward PE -0.59
Analyst n/a
Ask 0.31
Volume 80,624
Avg. Volume (20D) 6,324,922
Open 0.30
Previous Close 0.30
Day's Range 0.30 - 0.31
52-Week Range 0.21 - 2.52
Beta 0.71

About HCWB

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata ...

Industry Biotechnology
Sector Healthcare
IPO Date Jul 20, 2021
Employees 45
Stock Exchange NASDAQ
Ticker Symbol HCWB
Full Company Profile
1 month ago
+128.58%
HCW Biologics shares are trading higher after the ... Unlock content with Pro Subscription
4 months ago
+320.91%
HCW Biologics shares are trading higher after the company entered into an exclusive licensing deal with WY Biotech for immunotherapy development.